Researchers reveal that Visinin-like protein 1 promotes #AtrialFibrillation by impairing calcium homeostasis via NCX-1, highlighting a novel molecular target for treating #CardiacArrhythmias.
#STTT #OpenAccess: doi.org/10.1038/s413...
AI-enabled handheld detection of AF recurrence after ablation.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #DeepLearning #DigitalHealth #CardioSky #MedSky
AFib isn't just about the heart - new research reveals it may hamper the brain's waste-clearing system, linking it to cognitive decline. www.news-medical.net/news/2026033... #AtrialFibrillation #Neurology #CognitiveDecline @escardio.bsky.social
Atrial fibrillation can cause palpitations, breathlessness, dizziness, or tiredness — and it can also raise stroke risk.
Our guide explains symptoms, diagnosis, blood thinners and when to seek urgent help:
allhealthandcare.co.uk/resources/at...
#AtrialFibrillation #AFib #StrokePrevention
🫀 Just published online in JPS❣️
“Physiological doses of eicosapentaenoic acid suppress high-fat diet–induced atrial fibrillation in mice independent of lipid lowering”
— Kosuke Horii et al.
🔗 doi.org/10.1016/j.jp...
#AtrialFibrillation #EPA #CardiacProtection #Metabolism #NowOnline #JPhysiolSci
JAMA Cardiology article published online March 29, 2026, presents cumulative event-free survival curves stratified by serum neurofilament light chain (sNfL) quartiles (Qs) for major vascular events, nonfatal stroke, myocardial infarction and cardiovascular death.
Among patients with #AtrialFibrillation, higher serum neurofilament light chain levels were associated with increased risk of major vascular events, stroke, cardiovascular death, and heart failure hospitalization.
#ACC2026 @accintouch.bsky.social
ja.ma/3O4Tkmk
Predictors & impact of early AF recurrence after RF ablation.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #Ablation #Outcomes #CardioSky #MedSky
Adipokines contribute to AF pathophysiology.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #Adipokines #Pathophysiology #CardioSky #MedSky
Serum uric acid associated with AF burden.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #UricAcid #Risk #CardioSky #MedSky
Catheter ablation as first-line therapy for AF—clinical implications.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #CatheterAblation #Arrhythmia #CardioSky #MedSky
Atrial fibrillation & electrophysiology in CVIA—mechanisms, biomarkers & ablation advances.
cvia-journal.org
#AtrialFibrillation #Electrophysiology #Cardiology #CardioSky #MedSky
CRNM Bleeding for Abelacimab vs Rivaroxaban. Graph A shows bleeding rates per 100 patient-years stratified by age. Graph B shows probability of major/CRNM bleeding at text@2.3y. The rivaroxaban probability rises with age, while abelacimab remains stable.
Among older patients with #AtrialFibrillation, abelacimab reduced major or clinically relevant bleeding vs rivaroxaban, with a greater absolute risk reduction in those aged ≥75 years. ja.ma/3ZZ0T0i
The forest plot displays hazard ratios (aHR) with 95% confidence intervals for age and cardiovascular mortality. aHR decreases with age, starting at 0.66 for ages 70+ down to 0.73 for 80+. Cardiovascular mortality also decreases, from 0.52 for 70+ to 0.51 for 80+.
A village doctor-led, telemedicine-supported model improved cardiovascular outcomes and ABC pathway adherence in rural patients aged 75 years or older with #AtrialFibrillation compared with usual care. ja.ma/4uwtWXa
#AF + increase in HAS-BLED score and OAC discontinuation ⬇️
📌 Rungpradubvong et al. (COOL-AF): OAC discontinuation → ⬆️ mortality (aHR 3.66) & major bleeding (aHR 2.60)
📌 ⬆️ HAS-BLED = optimize risk, not stop OAC
👉 www.thieme-connect.de/products/ejo...
#CardioSky #AtrialFibrillation
JAMA Neurology graphic detailing an RCT on catheter ablation and oral anticoagulation for secondary stroke prevention in atrial fibrillation. Key points: Population (187 men, 62 women, mean age 71.7y), Intervention (249 patients), and Findings(no significant difference).
In patients with #AtrialFibrillation and recent #stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy.
ja.ma/4ui1isp
Final reminder.
The iCARDIO AF Survey closes tomorrow, 8 March.
Share your real-world insights on AF diagnosis, anticoagulation uptake, and #StrokePrevention across healthcare systems.
Submit before the deadline:
icardioalliance.org/surveys/
#AtrialFibrillation #Cardiology #iCARDIO
The iCARDIO Atrial Fibrillation (AF) Survey closes 8 March.
Share your real-world insights on AF diagnosis, anticoagulation, stroke prevention, and care barriers.
Submit before the deadline:
icardioalliance.org/surveys/
#AtrialFibrillation #Cardiology #StrokePrevention #iCARDIO
Last chance to apply for our #PhD position for UK/EU students @cardiffuni.bsky.social investigating how steroid sulfatase deficiency results in increased #arrhythmia #atrialfibrillation risk #cardiology #psychology www.findaphd.com/phds/project...
📰 BREAKING NEWS 📰
The European Heart Rhythm Association has released their 2025 survey on how atrial fibrillation (AF) is being treated in cancer patients and survivors.
Read the study: academic.oup.com/europace/art...
#cardioonc #cardiooncology #cardiology #atrialfibrillation
1/
I developed #AtrialFibrillation as a consequence of #LongCOVID. My heart rate could reach 250bpm, while just sitting -
My #LongCOVID heart rate could get up to 250bpm just sitting still. It took 4 years & an episode of #AtrialFibrillation at #Whitehorse ER, before I got a prescription for beta blockers. Until then, my family doc referred me to a supervised exercise programme, while "waiting & seeing" -
The image contains four bar graphs labeled A to D. A and C show 'Medical cost associated with AF' by sex and rurality, respectively. B and D show 'Productivity loss cost associated with AF' by sex and rurality, respectively. Each graph compares different cost factors.
Among privately insured working-age US employees, #AtrialFibrillation was associated with $11,393 excess annual medical costs—mainly from outpatient care—and $840 greater productivity losses per person, affirming substantial economic burden.
ja.ma/4kGJpPS
Atrial Fibrillation care differs across regions and clinical settings.
The iCARDIO Global Survey on AF is now live and invites physicians to share real-world perspectives.
Anonymous. 10 minutes.
icardioalliance.org/surveys/
#cardiosky #medsky #AtrialFibrillation #Cardiology #GlobalGuidelines
😊 Follow our Cardiology & Heart Health starter package! 🫀
(scientists, research projects, hospitals, university departments, journals, companies, organisations & patient groups)
👉 go.bsky.app/TxzoAP1
#AtrialFibrillation #AFib #AFBurden #cardiology #HeartHealth #HeartFailure #CardioSky #CardioNews
☺️ Our interactive, successful, and fun #KickoffMeeting in #Amsterdam was wrapped up with democratic elections of important advisory boards & a motivating conclusion by Paulus Kirchhof & Christiana Krammer. Until next time!
#AF #AFib #AtrialFibrillation #arrhythmia #AFBurden #cardiosky #HeartHealth
Productive breakout sessions by WP5 & WP8 researchers at our #KickoffMeeting resulted in increased awareness of the key technological + scientific challenges and decisions on how to tackle them!
We win if we can avert #HeartFailure!🫀😎
#AF #AFib #AtrialFibrillation #AI #explainableAI #HeartRhythm
History lesson on #electrocardiography #ECGs in Prof. Fu Siong Ng’s talk!
🫀🩺😅
👉 WP8 - Predictors of no/low, intermediate, and high #AFBurden in patients: pathways for targeted #HeartRhythm monitoring (WP8 lead: Prof. Barbara Casadei
from @imperialcollegeldn.bsky.social)
#AFib #AtrialFibrillation
Two graphs compare bleeding with abelacimab vs. rivaroxaban. Graph A: bar graph shows incidence rate per 100 patient-years stratified by age. Graph B: probability of major bleeding vs. age for rivaroxaban and abelacimab pooled dose.
Among older patients with #AtrialFibrillation, abelacimab reduced major or clinically relevant bleeding vs rivaroxaban, with a greater absolute risk reduction in those aged ≥75 years. bit.ly/4alEy1P
🫀 Work package 6 (WP6) leader, Dr. med. Nina Becher from UKE, Hamburg, points out that #AFib assessment differs substantially across #CIEDs (pacemakers, #ICDs, implantable
loop recorders)!
👉 WP6 topic: “Standards for #AtrialFibrillation burden reporting by cardiac #implantable electronic devices”
⏳ Early interaction 📆 with the European Medicines Agency #EMA is key for proper exploitation + real-life regulatory impact of our @ihieurope.bsky.social funded project - based on advice from project leader Mirko de Melis and Acesion Pharma consortium members.
#AF #AtrialFibrillation #AFib #AFBurden